The U.S. Food and Drug Administration today approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo). This is the first drug approved for this use.
Recent Blog Posts
The U.S. Food and Drug Administration approved Actemra (tocilizumab) to treat adults with moderate to severe rheumatoid arthritis who have not adequately responded to or cannot tolerate other approved drug classes for rheumatoid arthritis.
Scientists claimed to have developed a slimming pill that can burn off as many calories as 80 minutes of walk or a 25-minute jog, while you sit.
The pill - Capsiplex - which is made from hot peppers and capsicum, utilises the weight-loss potential of red-hot peppers.
Scientists are now recommending tomatoes as an healthy alternative to aspirin.
Clinical trials have shown that the natural gel in tomato seeds can prevent clotting and improve blood circulation in the body.
The colourless, tasteless gel can be added to various foods and consumed.
In fact, it is already being used in one fruit juice product Fruitflow.